HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Po Yee Chiu Selected Research

Glutathione (Reduced Glutathione)

3/2012Cytochrome P-450-catalyzed reactive oxygen species production mediates the (-)schisandrin B-induced glutathione and heat shock responses in H9c2 cardiomyocytes.
4/2011Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in H9c2 cells.
11/2009Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and associated changes in the Ca(2+)-induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes.
5/2008Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes.
1/2003Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Po Yee Chiu Research Topics

Disease

6Reperfusion Injury
08/2011 - 01/2003
5Hypoxia (Hypoxemia)
03/2012 - 05/2008
3Coronary Disease (Coronary Heart Disease)
08/2011 - 02/2011
3Myocardial Ischemia (Ischemic Heart Diseases)
02/2008 - 11/2004
2Brain Ischemia (Cerebral Ischemia)
07/2012 - 07/2008
2Atherosclerosis
08/2011 - 04/2011
2Ischemia
11/2004 - 01/2003
1Stroke (Strokes)
07/2012
1Neuroblastoma
07/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2012
1Myocardial Infarction
02/2011
1Hepatitis
11/2004

Drug/Important Bio-Agent (IBA)

5Glutathione (Reduced Glutathione)IBA
03/2012 - 01/2003
5schizandrin BIBA
11/2009 - 01/2003
4Danshen-GegenIBA
01/2012 - 02/2011
3Pharmaceutical PreparationsIBA
03/2012 - 05/2008
3AntioxidantsIBA
03/2012 - 07/2008
3Adenosine Triphosphate (ATP)IBA
08/2011 - 01/2003
2Caspase 3 (Caspase-3)IBA
11/2009 - 05/2008
2schizandrinIBA
11/2009 - 05/2008
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2009 - 05/2008
2Cytochromes c (Cytochrome c)IBA
11/2009 - 05/2008
1DNA (Deoxyribonucleic Acid)IBA
07/2012
1Proteins (Proteins, Gene)FDA Link
07/2012
1Amyloid (Amyloid Fibrils)IBA
07/2012
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2012
1Methanol (Carbinol)IBA
01/2012
1U 0126 (UO 126)IBA
04/2011
1Protein Kinase CIBA
04/2011
1Gentamicins (Gentamicin)FDA LinkGeneric
02/2008
1DDBIBA
08/2005
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2004